Additionally, both treatments resulted in reduced tumor-related architectural tissue distortion (Figure 2C), CD8+ T cell infiltration (Supplementary Figure 2A), Olig2+ cell content (Supplementary Figure 2B), and BLBP+ cell content (Supplementary Figure 2C). The gene discussed is OLIG2; the disease is neoplasm.